Dose dense chemotherapy might be the only modifiable factor associated with distant recurrence in high-risk patients with endometrial cancer
Autor: | Matanes, E., Mitric, C., Amajoud, Z., Abitbol, J., Eisenberg, N., Nazer, A., López-Ozuna, V., Yasmeen, A., Salvador, S., Lau, S., Gotlieb, W.H., Kogan, L. |
---|---|
Zdroj: | In Gynecologic Oncology October 2020 159 Supplement 1:213-214 |
Databáze: | ScienceDirect |
Externí odkaz: |